Takero Shindo1,2, Hidekazu Itamura2, Satoshi Yoshioka3, Takayuki Ishikawa3, Shinya Kimura2 (1.Hematology, Kyoto University, Kyoto, Japan, 2.Hematology, Respiratory Medicine and Oncology, Saga University, Saga, Japan, 3.Hematology, Kobe City Medical Center General Hospital, Kobe, Japan)
Session information
Oral Session
Oral Session 1-12C GVHD
Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.12 (Osaka International Convention Center, 10F 1006-7)
Chair: Yoshinobu Maeda (Department of Hematology and Oncology, Okayama University Hospital, Japan)
【E】
Xiuhua Su (Hematopoietic Stem Cell Transplantation Center, Institute of Hematology,Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, People's Republic of China)
Reiki Ogasawara, Daigo Hashimoto, Eiko Hayase, Shuichiro Takahashi, Takahide Ara, Hiroyuki Ohhigashi, Kosuke Yoshioka, Takahiro Tateno, Takanori Teshima (Hematol., Hokkaido Univ., Sapporo, Japan)
Kohta Miyawaki, Takeshi Sugio, Kensuke Sasaki, Koji Kato, Koichi Akashi (Dept of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan)
Tomomi Toubai1,2, Corrine Rossi2, Isao Tawara3, Kenichi Ishizawa1, Pavan Reddy2 (1.Hematology and Cell Therapy, Yamagata Univ, Yamagata, Japan, 2.Hematology & Oncology, Univ Michigan, Ann Arbor, USA, 3.Hematology & Oncology, Mie Univ, Tsu, Japan)
Ryo Hatano1, Haruna Otsuka1, Eriko Komiya2, Takumi Itoh1, Noriaki Iwao3, Taketo Yamada4, Chikao Morimoto1, Kei Ohnuma1 (1.Graduate School of Medicine, Juntendo University, Tokyo, Japan, 2.Juntendo University Graduate School of Medicine, Urayasu, Japan, 3.Department of Hematology, Juntendo University Shizuoka Hospital, Shizuoka, Japan, 4.Department of Pathology, Saitama Medical University, Saitama, Japan)